Engraftment Is Optimal When Myoblasts Are Transplanted Early: The Role of Hepatocyte Growth Factor

Annals of Thoracic Surgery

Volumn 89, Issue 3, 2010, Pages 829-835

  O'Blenes, Stacy B ^a   Li, Audrey W ^a   Chen, Robert ^a   Arora, Rakesh C ^b   Horackova, Magda ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENGRAFTMENT; HEART MUSCLE; HYPOXIA; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; CELL HYPOXIA; CELL PROLIFERATION; GRAFT SURVIVAL; HEART; HEPATOCYTE GROWTH FACTOR; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; VENTRICULAR FUNCTION, LEFT;

EID: 76749134657     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.12.007     Document Type: Article

References (33)

1. Terrovitis J., Lautamaki R., Bonios M., et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54 (2009) 1619-1626
2. Johnston P.V., Sasano T., Mills K., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120 (2009) 1075-1083 7
3. Moretti A., Bellin M., Jung C.B., et al. Mouse and human induced pluripotent stem cells as a source for multipotent Is11+ cardiovascular progenitors. FASEB J (2009 Oct 22)
4. Zwi L., Caspi O., Arbel G., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120 (2009) 1513-1523
5. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355 (2006) 1274-1277
6. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
7. Ghostine S., Carrion C., Souza L.C., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106 12 Suppl 1 (2002) I-131-I-136
8. Al Attar N., Carrion C., Ghostine S., et al. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc Res 58 (2003) 142-148
9. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117 (2008) 1189-1200
10. Morgan J.E., and Partridge T.A. Muscle satellite cells. Int J Biochem Cell Biol 35 (2003) 1151-1156
11. Hawke T.J., and Garry D.J. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91 (2001) 534-551
12. Husmann I., Soulet L., Gautron J., Martelly I., and Barritault D. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 7 (1996) 249-258
13. Wagers A.J., and Conboy I.M. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122 (2005) 659-667
14. Ono K., Matsumori A., Shioi T., Furukawa Y., and Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95 (1997) 2552-2558
15. Zhu Y., Hojo Y., Ikeda U., and Shimada K. Production of hepatocyte growth factor during acute myocardial infarction. Heart 83 (2000) 450-455
16. Ueda H., Nakamura T., Matsumoto K., Sawa Y., Matsuda H., and Nakamura T. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats. Cardiovasc Res 51 (2001) 41-50
17. Pouzet B., Vilquin J.T., Hagege A.A., et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?. Circulation 102 19 Suppl 3 (2000) III-210-III-215
18. Tolivia J., Navarro A., del Valle E., Perez C., Ordonez C., and Martinez E. Application of Photoshop and Scion Image analysis to quantification of signals in histochemistry, immunocytochemistry and hybridocytochemistry. Anal Quant Cytol Histol 28 (2006) 43-53
19. Kajio T., Kawahara K., and Kato K. Quantitative colorimetric assay for basic fibroblast growth factor using bovine endothelial cells and heparin. J Pharmacol Toxicol Methods 28 (1992) 9-14
20. Fishbein M.C., Maclean D., and Maroko P.R. The histopathologic evolution of myocardial infarction. Chest 73 (1978) 843-849
21. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
22. McCue J.D., Swingen C., Feldberg T., et al. The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J Heart Lung Transplant 27 (2008) 116-123
23. Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
24. Li R.K., Mickle D.A., Weisel R.D., Rao V., and Jia Z.Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 72 (2001) 1957-1963
25. Farahmand P., Lai T.Y., Weisel R.D., et al. Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation 118 14 Suppl (2008) S130-S137
26. Sheehan S.M., Tatsumi R., Temm-Grove C.J., and Allen R.E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 23 (2000) 239-245
27. Wang X., Zhou Y., Kim H.P., et al. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem 279 (2004) 5237-5243
28. Tambara K., Premaratne G.U., Sakaguchi G., et al. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112 9 Suppl (2005) I-129-I-134
29. Miyagawa S., Sawa Y., Taketani S., et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 105 (2002) 2556-2561
30. Inoue T., Ide T., Yamato M., et al. Time-dependent changes of myocardial and systemic oxidative stress are dissociated after myocardial infarction. Free Radic Res 43 (2009) 37-46
31. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 81 (2009) 482-490
32. Hill M.F., and Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148 (1996) 291-300
33. Kitta K., Day R.M., Ikeda T., and Suzuki Y.J. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 31 (2001) 902-910